Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel
- PMID: 8501843
- DOI: 10.1001/jama.269.23.3009
Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel
Abstract
Objective: To estimate the current levels and trends in the proportion of US adults with high blood cholesterol based on guidelines from the second report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP II).
Design: Nationally representative cross-sectional surveys.
Setting/participants: Data for 7775 participants 20 years of age and older from phase 1 of the third National Health and Nutrition Examination Survey (NHANES III) (data collected from 1988 through 1991) and for 9797 participants 20 through 74 years of age from NHANES II (data collected from 1976 through 1980) were used.
Results: From the data collection period in NHANES II (1976 through 1980) to the period in NHANES III (1988 through 1991), the proportion of adults with high blood cholesterol levels (> or = 240 mg/dL [6.21 mmol bd) fell from 26% to 20%, while the proportion with desirable levels (< 200 mg/dL [5.17 mmol/L]) rose from 44% to 49%. Currently, using the ATP II guidelines and NHANES III data, 40% of all adults 20 years of age and older would require fasting lipoprotein analysis; and 29% of all adults would be candidates for dietary therapy (as compared with 36%, using NHANES II data). Based on 1990 population data, it is estimated that approximately 52 million Americans 20 years of age and older would be candidates for dietary therapy. Assuming that dietary intervention would reduce low-density lipoprotein (LDL) cholesterol levels by 10%, as many as 7% of all adult Americans (approximately 12.7 million) might be candidates for cholesterol-lowering drugs. This estimate reflects approximately 4 million adults with established coronary heart disease, of whom half are aged 65 years and older, and up to 8.7 million adults without established coronary heart disease, of whom up to 3.1 million are aged 65 years and older.
Conclusions: Substantial progress has been made in reducing the prevalence of high blood cholesterol; yet a large proportion of all adults, approximately 29%, require dietary intervention for high blood cholesterol.
Comment in
-
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).JAMA. 1993 Jun 16;269(23):3015-23. JAMA. 1993. PMID: 8501844 No abstract available.
Similar articles
-
Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.MMWR Morb Mortal Wkly Rep. 2011 Feb 4;60(4):109-14. MMWR Morb Mortal Wkly Rep. 2011. PMID: 21293326
-
Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. National Health and Nutrition Examination Survey.Arch Intern Med. 2000 May 8;160(9):1361-9. doi: 10.1001/archinte.160.9.1361. Arch Intern Med. 2000. PMID: 10809042
-
Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006.JAMA. 2009 Nov 18;302(19):2104-10. doi: 10.1001/jama.2009.1672. JAMA. 2009. PMID: 19920234
-
An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.JAMA. 1999 Dec 1;282(21):2051-7. doi: 10.1001/jama.282.21.2051. JAMA. 1999. PMID: 10591388 Review.
-
Plasma lipids and lipoprotein concentrations among American Indians: comparison with the US population.Curr Opin Lipidol. 1996 Aug;7(4):188-95. doi: 10.1097/00041433-199608000-00003. Curr Opin Lipidol. 1996. PMID: 8883492 Review.
Cited by
-
Metabolic risks in older adults receiving second-generation antipsychotic medication.Curr Psychiatry Rep. 2009 Feb;11(1):33-40. doi: 10.1007/s11920-009-0006-0. Curr Psychiatry Rep. 2009. PMID: 19187706 Review.
-
The physician and pharmacist team. An effective approach to cholesterol reduction.J Gen Intern Med. 1997 Mar;12(3):158-64. doi: 10.1007/s11606-006-5023-7. J Gen Intern Med. 1997. PMID: 9100140 Free PMC article. Clinical Trial.
-
Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction.J Gen Intern Med. 2002 Feb;17(2):95-102. doi: 10.1046/j.1525-1497.2002.10438.x. J Gen Intern Med. 2002. PMID: 11841524 Free PMC article.
-
Dyslipoproteinaemia in a subset of patients with rheumatoid arthritis.Ann Rheum Dis. 1994 Aug;53(8):551-2. doi: 10.1136/ard.53.8.551. Ann Rheum Dis. 1994. PMID: 7944646 Free PMC article. No abstract available.
-
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.Eur J Epidemiol. 2007;22(12):839-69. doi: 10.1007/s10654-007-9165-7. Epub 2007 Sep 18. Eur J Epidemiol. 2007. PMID: 17876711
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical